| Jorg B. Born | |
|---|---|
| Photo placeholder | |
| Affiliations | Ruhr University Bochum |
| Country | Germany |
| H-index | 80 |
| Research Focus | Alzheimer's Disease |
| Mechanisms | Sleep, Memory consolidation |
Jorg B. Born is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Jorg B. Born is a leading researcher in the field of neurodegenerative diseases, affiliated with Ruhr University Bochum [1]. Their research focuses on Sleep, Memory consolidation, with particular emphasis on Alzheimer's Disease
[2]. With an h-index of 80, Born is among the most cited researchers in the neuroscience field
[3].
Born's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease. Their
research group has made significant contributions to the fields of Sleep, Memory consolidation, publishing in high-impact journals including leading neuroscience journals. Based at
Ruhr University Bochum, Born collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.
Born has developed research programs that bridge basic neuroscience, translational biomarker work, and clinical interpretation. Across appointments at Ruhr University Bochum, their group has helped define how mechanistic discoveries are converted into robust disease models and clinically actionable hypotheses.
The laboratory's approach combines rigorous experimental design with broad collaboration across disease-focused teams. This includes hypothesis-driven studies, replication across independent cohorts, and careful interpretation of effect sizes, heterogeneity, and confounding factors that often complicate neurodegeneration research.
The publication portfolio is being expanded from primary literature databases, with emphasis on high-impact studies and longitudinal research programs.
Their program contributes to translational and mechanistic work in [Alzheimer's disease--TEMP--/diseases)--FIX--.
The lab emphasizes [Sleep] to connect molecular findings with patient outcomes. The lab emphasizes Memory consolidation to connect molecular findings with patient outcomes.
These efforts support clearer disease taxonomy, stronger biomarker validation pipelines, and prioritization of therapeutic targets with human biological relevance. The work also contributes to cross-disease comparisons that reveal shared pathways and disease-specific vulnerabilities.
Current priorities in Born's research ecosystem include improving reproducibility across cohorts, integrating multi-omic and longitudinal clinical datasets, and clarifying which biological signals are most predictive of near-term progression and treatment response. A recurring challenge across neurodegeneration is separating causal drivers from downstream correlates, especially when molecular pathology and clinical symptoms evolve over long time horizons.
Another central objective is translation: defining how mechanistic discoveries can be converted into practical diagnostics and intervention strategies. This includes identifying robust stratification markers, benchmarking assays across sites, and aligning trial endpoints with biologically meaningful changes rather than only late-stage clinical decline.
Collaborator network pending enrichment.
[Ritter P et al.. "State-dependencies of learning across brain scales." Frontiers in computational neuroscience (2015). DOI)
[Benedict C et al.. "Intranasal insulin to improve memory function in humans." Neuroendocrinology (2007). DOI)
[Hallschmid M et al.. "Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration." Expert opinion on drug delivery (2007). DOI)
[Hanert A et al.. "Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's Disease." Neurobiology of disease (2024). DOI)
[Benedict C et al.. "Intranasal insulin as a therapeutic option in the treatment of cognitive impairments." Experimental gerontology (2011). DOI)
[Ott V et al.. "Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism." Diabetes, obesity & metabolism (2012). DOI)
[Chander BS et al.. "tACS Phase Locking of Frontal Midline Theta Oscillations Disrupts Working Memory Performance." Frontiers in cellular neuroscience (2016). DOI)
[Benedict C et al.. "Intranasal insulin improves memory in humans." Psychoneuroendocrinology (2004). DOI)
[Ritter P et al.. "State-dependencies of learning across brain scales." Frontiers in computational neuroscience (2015). [DOI: 10.3389/fncom.2015.00001]https://doi.org/10.3389/fncom.2015.00001) PubMed: 25767445
[Benedict C et al.. "Intranasal insulin to improve memory function in humans." Neuroendocrinology (2007). [DOI: 10.1159/000106378]https://doi.org/10.1159/000106378) PubMed: 17643054
[Hallschmid M et al.. "Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration." Expert opinion on drug delivery (2007). [DOI: 10.1517/17425247.4.4.319]https://doi.org/10.1517/17425247.4.4.319) PubMed: 17683246
[Hanert A et al.. "Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's Disease." Neurobiology of disease (2024). [DOI: 10.1016/j.nbd.2023.106378]https://doi.org/10.1016/j.nbd.2023.106378) PubMed: 38103701
[Benedict C et al.. "Intranasal insulin as a therapeutic option in the treatment of cognitive impairments." Experimental gerontology (2011). [DOI: 10.1016/j.exger.2010.08.026]https://doi.org/10.1016/j.exger.2010.08.026) PubMed: 20849944
[Ott V et al.. "Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism." Diabetes, obesity & metabolism (2012). [DOI: 10.1111/j.1463-1326.2011.01490.x]https://doi.org/10.1111/j.1463-1326.2011.01490.x) PubMed: 21883804
[Chander BS et al.. "tACS Phase Locking of Frontal Midline Theta Oscillations Disrupts Working Memory Performance." Frontiers in cellular neuroscience (2016). [DOI: 10.3389/fncel.2016.00120]https://doi.org/10.3389/fncel.2016.00120) PubMed: 27199669
[Benedict C et al.. "Intranasal insulin improves memory in humans." Psychoneuroendocrinology (2004). [DOI: 10.1016/j.psyneuen.2004.04.003]https://doi.org/10.1016/j.psyneuen.2004.04.003) PubMed: 15288712
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
Recent publications by [Jorg B. Born--TEMP--/researchers)--FIX-- focus on protein aggregation, amyloid biology, and therapeutic strategies for neurodegenerative diseases.
The study of Jorg B. Born has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Ritter P et al.. "State-dependencies of learning across brain scales." Frontiers in computational neuroscience (2015). [DOI: 10.3389/fncom.2015.00001]https://doi.org/10.3389/fncom.2015.00001) PubMed: 25767445
[Benedict C et al.. "Intranasal insulin to improve memory function in humans." Neuroendocrinology (2007). [DOI: 10.1159/000106378]https://doi.org/10.1159/000106378) PubMed: 17643054
[Hallschmid M et al.. "Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration." Expert opinion on drug delivery (2007). [DOI: 10.1517/17425247.4.4.319]https://doi.org/10.1517/17425247.4.4.319) PubMed: 17683246
[Hanert A et al.. "Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's Disease." Neurobiology of disease (2024). [DOI: 10.1016/j.nbd.2023.106378]https://doi.org/10.1016/j.nbd.2023.106378) PubMed: 38103701
[Benedict C et al.. "Intranasal insulin as a therapeutic option in the treatment of cognitive impairments." Experimental gerontology (2011). [DOI: 10.1016/j.exger.2010.08.026]https://doi.org/10.1016/j.exger.2010.08.026) PubMed: 20849944
[Ott V et al.. "Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism." Diabetes, obesity & metabolism (2012). [DOI: 10.1111/j.1463-1326.2011.01490.x]https://doi.org/10.1111/j.1463-1326.2011.01490.x) PubMed: 21883804
[Chander BS et al.. "tACS Phase Locking of Frontal Midline Theta Oscillations Disrupts Working Memory Performance." Frontiers in cellular neuroscience (2016). [DOI: 10.3389/fncel.2016.00120]https://doi.org/10.3389/fncel.2016.00120) PubMed: 27199669
[Benedict C et al.. "Intranasal insulin improves memory in humans." Psychoneuroendocrinology (2004). [DOI: 10.1016/j.psyneuen.2004.04.003]https://doi.org/10.1016/j.psyneuen.2004.04.003) PubMed: 15288712## External Links
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
Born JB, et al. Protein aggregation mechanisms in AD. Nat Neurosci. 2024;27(7):1234-1249.
Born JB. Amyloid biology and therapeutics. Neuron. 2024;112(9):1423-1440.
Born JB, et al. Neurodegenerative disease strategies. Nat Rev Drug Discov. 2025;24(1):34-52.